SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-05-013999
Filing Date
2005-05-09
Accepted
2005-05-09 17:16:09
Documents
7
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a2156938z10-q.htm 10-Q 200576
2 EXHIBIT 10.1 a2156938zex-10_1.htm EX-10.1 42740
3 EXHIBIT 10.2 a2156938zex-10_2.htm EX-10.2 58114
4 EXHIBIT 10.3 a2156938zex-10_3.htm EX-10.3 40466
5 EXHIBIT 31.1 a2156938zex-31_1.htm EX-31.1 6451
6 EXHIBIT 31.2 a2156938zex-31_2.htm EX-31.2 6429
7 EXHIBIT 32.1 a2156938zex-32_1.htm EX-32.1 3456
  Complete submission text file 0001047469-05-013999.txt   359529
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 05812761
SIC: 2834 Pharmaceutical Preparations